Helix Biopharma Corp. To Present at the Biotech Showcase Conference During the Annual JP Morgan Week in San Francisco

(Toronto, Ontario) – Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a clinical stage immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, intends to meet a selection of Big Pharma and Big Biotech companies during the Annual JP Morgan Conference week in San Francisco during January 9-12, 2017.  In addition, Helix has been selected to present at the Biotech Showcase Conference on Tuesday, January 10, 2016 at 9:30am at Hilton San Francisco Union Square, which runs in parallel to the JP Morgan Conference.